Is an “à la carte” combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C?
Thierry Poynard, John McHutchison, Zachary Goodman, Mei-Hsiu Ling, Janice AlbrechtVolume:
31
Année:
2000
Langue:
english
Pages:
8
DOI:
10.1002/hep.510310131
Fichier:
PDF, 215 KB
english, 2000